Loading…
Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation
The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interac...
Saved in:
Published in: | Investigative ophthalmology & visual science 2010-03, Vol.51 (3), p.1709-1718 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3 |
---|---|
cites | |
container_end_page | 1718 |
container_issue | 3 |
container_start_page | 1709 |
container_title | Investigative ophthalmology & visual science |
container_volume | 51 |
creator | Rojas, Modesto Zhang, Wenbo Lee, Dexter L Romero, Maritza J Nguyen, Doan T Al-Shabrawey, Mohamed Tsai, Nai-Tse Liou, Gregory I Brands, Michael W Caldwell, Robert W Caldwell, Ruth B |
description | The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interactions between inflammatory agonists and angiotensin II in promoting retinopathy are poorly understood. The present study was an investigation of the role of interleukin (IL)-6 in angiotensin II-induced retinopathy.
Rats and IL-6-deficient and wild-type mice were treated with angiotensin II or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localization of VEGF or IL-6. Leukocyte adhesion was assayed by concanavalin A labeling. Vascular density was determined by morphometric analysis. NADPH oxidase activity was assayed by dihydroethidium imaging of superoxide.
Intravitreal injection of angiotensin II caused increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels. IL-6 protein was localized to CD11b-positive microglia and macrophage-like cells. Angiotensin II treatment stimulated increases in retinal levels of VEGF expression and NADPH oxidase activity, which were associated with increased surface area and remodeling of the retinal vessels. These effects were blocked by knocking out IL-6. Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient mice.
The results indicate that IL-6 expression is essential for angiotensin II-induced increases in retinal VEGF expression, leukostasis, and vascular remodeling. The data suggest a critical role for IL-6 in mediating angiotensin II-induced retinal vascular inflammation and remodeling. |
doi_str_mv | 10.1167/iovs.09-3375 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2868419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19834028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3</originalsourceid><addsrcrecordid>eNpVkE1r4zAQhsXSsk3bvfVcfOqpzs7oy9alUPppCCyU7V6FLEuJii0Xy2nYf1-HhH6cZmCe9x14CDlDmCPK4nfo39IcVM5YIX6QGQpBc1GU7IDMALnMgQM_IscpvQBQRAo_yRGqknGg5YzcPvWty3qfVYtcZiFm13EZ-tHFNO1VlVexWVvXZE9uDNG02T-T7Lo1Q1ZF35quM2Po4yk59KZN7td-npDn-7u_N4_54s9DdXO9yC0vYcyplyhKZB6g5qpWXHovZGMNctooBC6kZUxRKYByRmlTgFeiblxd1NI6y07I1a73dV13rrEujoNp9esQOjP8170J-vslhpVe9m-alrLkqKaCy12BHfqUBuc_sgh6a1NvbWpQemtzws-__vuE9_om4GIHrMJytQmD06kzbTvhqDebjUDNNBag2Ds30X2-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation</title><source>PubMed Central</source><creator>Rojas, Modesto ; Zhang, Wenbo ; Lee, Dexter L ; Romero, Maritza J ; Nguyen, Doan T ; Al-Shabrawey, Mohamed ; Tsai, Nai-Tse ; Liou, Gregory I ; Brands, Michael W ; Caldwell, Robert W ; Caldwell, Ruth B</creator><creatorcontrib>Rojas, Modesto ; Zhang, Wenbo ; Lee, Dexter L ; Romero, Maritza J ; Nguyen, Doan T ; Al-Shabrawey, Mohamed ; Tsai, Nai-Tse ; Liou, Gregory I ; Brands, Michael W ; Caldwell, Robert W ; Caldwell, Ruth B</creatorcontrib><description>The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interactions between inflammatory agonists and angiotensin II in promoting retinopathy are poorly understood. The present study was an investigation of the role of interleukin (IL)-6 in angiotensin II-induced retinopathy.
Rats and IL-6-deficient and wild-type mice were treated with angiotensin II or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localization of VEGF or IL-6. Leukocyte adhesion was assayed by concanavalin A labeling. Vascular density was determined by morphometric analysis. NADPH oxidase activity was assayed by dihydroethidium imaging of superoxide.
Intravitreal injection of angiotensin II caused increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels. IL-6 protein was localized to CD11b-positive microglia and macrophage-like cells. Angiotensin II treatment stimulated increases in retinal levels of VEGF expression and NADPH oxidase activity, which were associated with increased surface area and remodeling of the retinal vessels. These effects were blocked by knocking out IL-6. Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient mice.
The results indicate that IL-6 expression is essential for angiotensin II-induced increases in retinal VEGF expression, leukostasis, and vascular remodeling. The data suggest a critical role for IL-6 in mediating angiotensin II-induced retinal vascular inflammation and remodeling.</description><identifier>ISSN: 0146-0404</identifier><identifier>ISSN: 1552-5783</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.09-3375</identifier><identifier>PMID: 19834028</identifier><language>eng</language><publisher>United States: ARVO</publisher><subject>Angiotensin II - pharmacology ; Animals ; Blotting, Western ; Cell Adhesion ; Enzyme-Linked Immunosorbent Assay ; Interleukin-6 - pharmacology ; Interleukin-6 - physiology ; Leukocytes - metabolism ; Leukostasis - chemically induced ; Leukostasis - prevention & control ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Microscopy, Confocal ; NADPH Oxidases - metabolism ; Rats ; Rats, Sprague-Dawley ; Retinal Vasculitis - chemically induced ; Retinal Vasculitis - metabolism ; Retinal Vessels - drug effects ; Retinal Vessels - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - metabolism ; Superoxides - metabolism ; Up-Regulation ; Vascular Endothelial Growth Factor A - metabolism ; Vasoconstrictor Agents - pharmacology</subject><ispartof>Investigative ophthalmology & visual science, 2010-03, Vol.51 (3), p.1709-1718</ispartof><rights>Copyright © Association for Research in Vision and Ophthalmology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868419/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868419/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19834028$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rojas, Modesto</creatorcontrib><creatorcontrib>Zhang, Wenbo</creatorcontrib><creatorcontrib>Lee, Dexter L</creatorcontrib><creatorcontrib>Romero, Maritza J</creatorcontrib><creatorcontrib>Nguyen, Doan T</creatorcontrib><creatorcontrib>Al-Shabrawey, Mohamed</creatorcontrib><creatorcontrib>Tsai, Nai-Tse</creatorcontrib><creatorcontrib>Liou, Gregory I</creatorcontrib><creatorcontrib>Brands, Michael W</creatorcontrib><creatorcontrib>Caldwell, Robert W</creatorcontrib><creatorcontrib>Caldwell, Ruth B</creatorcontrib><title>Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation</title><title>Investigative ophthalmology & visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interactions between inflammatory agonists and angiotensin II in promoting retinopathy are poorly understood. The present study was an investigation of the role of interleukin (IL)-6 in angiotensin II-induced retinopathy.
Rats and IL-6-deficient and wild-type mice were treated with angiotensin II or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localization of VEGF or IL-6. Leukocyte adhesion was assayed by concanavalin A labeling. Vascular density was determined by morphometric analysis. NADPH oxidase activity was assayed by dihydroethidium imaging of superoxide.
Intravitreal injection of angiotensin II caused increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels. IL-6 protein was localized to CD11b-positive microglia and macrophage-like cells. Angiotensin II treatment stimulated increases in retinal levels of VEGF expression and NADPH oxidase activity, which were associated with increased surface area and remodeling of the retinal vessels. These effects were blocked by knocking out IL-6. Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient mice.
The results indicate that IL-6 expression is essential for angiotensin II-induced increases in retinal VEGF expression, leukostasis, and vascular remodeling. The data suggest a critical role for IL-6 in mediating angiotensin II-induced retinal vascular inflammation and remodeling.</description><subject>Angiotensin II - pharmacology</subject><subject>Animals</subject><subject>Blotting, Western</subject><subject>Cell Adhesion</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Interleukin-6 - pharmacology</subject><subject>Interleukin-6 - physiology</subject><subject>Leukocytes - metabolism</subject><subject>Leukostasis - chemically induced</subject><subject>Leukostasis - prevention & control</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Microscopy, Confocal</subject><subject>NADPH Oxidases - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Retinal Vasculitis - chemically induced</subject><subject>Retinal Vasculitis - metabolism</subject><subject>Retinal Vessels - drug effects</subject><subject>Retinal Vessels - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - metabolism</subject><subject>Superoxides - metabolism</subject><subject>Up-Regulation</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Vasoconstrictor Agents - pharmacology</subject><issn>0146-0404</issn><issn>1552-5783</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpVkE1r4zAQhsXSsk3bvfVcfOqpzs7oy9alUPppCCyU7V6FLEuJii0Xy2nYf1-HhH6cZmCe9x14CDlDmCPK4nfo39IcVM5YIX6QGQpBc1GU7IDMALnMgQM_IscpvQBQRAo_yRGqknGg5YzcPvWty3qfVYtcZiFm13EZ-tHFNO1VlVexWVvXZE9uDNG02T-T7Lo1Q1ZF35quM2Po4yk59KZN7td-npDn-7u_N4_54s9DdXO9yC0vYcyplyhKZB6g5qpWXHovZGMNctooBC6kZUxRKYByRmlTgFeiblxd1NI6y07I1a73dV13rrEujoNp9esQOjP8170J-vslhpVe9m-alrLkqKaCy12BHfqUBuc_sgh6a1NvbWpQemtzws-__vuE9_om4GIHrMJytQmD06kzbTvhqDebjUDNNBag2Ds30X2-</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Rojas, Modesto</creator><creator>Zhang, Wenbo</creator><creator>Lee, Dexter L</creator><creator>Romero, Maritza J</creator><creator>Nguyen, Doan T</creator><creator>Al-Shabrawey, Mohamed</creator><creator>Tsai, Nai-Tse</creator><creator>Liou, Gregory I</creator><creator>Brands, Michael W</creator><creator>Caldwell, Robert W</creator><creator>Caldwell, Ruth B</creator><general>ARVO</general><general>Association for Research in Vision and Ophthalmology, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20100301</creationdate><title>Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation</title><author>Rojas, Modesto ; Zhang, Wenbo ; Lee, Dexter L ; Romero, Maritza J ; Nguyen, Doan T ; Al-Shabrawey, Mohamed ; Tsai, Nai-Tse ; Liou, Gregory I ; Brands, Michael W ; Caldwell, Robert W ; Caldwell, Ruth B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Angiotensin II - pharmacology</topic><topic>Animals</topic><topic>Blotting, Western</topic><topic>Cell Adhesion</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Interleukin-6 - pharmacology</topic><topic>Interleukin-6 - physiology</topic><topic>Leukocytes - metabolism</topic><topic>Leukostasis - chemically induced</topic><topic>Leukostasis - prevention & control</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Microscopy, Confocal</topic><topic>NADPH Oxidases - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Retinal Vasculitis - chemically induced</topic><topic>Retinal Vasculitis - metabolism</topic><topic>Retinal Vessels - drug effects</topic><topic>Retinal Vessels - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - metabolism</topic><topic>Superoxides - metabolism</topic><topic>Up-Regulation</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Vasoconstrictor Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rojas, Modesto</creatorcontrib><creatorcontrib>Zhang, Wenbo</creatorcontrib><creatorcontrib>Lee, Dexter L</creatorcontrib><creatorcontrib>Romero, Maritza J</creatorcontrib><creatorcontrib>Nguyen, Doan T</creatorcontrib><creatorcontrib>Al-Shabrawey, Mohamed</creatorcontrib><creatorcontrib>Tsai, Nai-Tse</creatorcontrib><creatorcontrib>Liou, Gregory I</creatorcontrib><creatorcontrib>Brands, Michael W</creatorcontrib><creatorcontrib>Caldwell, Robert W</creatorcontrib><creatorcontrib>Caldwell, Ruth B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Investigative ophthalmology & visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rojas, Modesto</au><au>Zhang, Wenbo</au><au>Lee, Dexter L</au><au>Romero, Maritza J</au><au>Nguyen, Doan T</au><au>Al-Shabrawey, Mohamed</au><au>Tsai, Nai-Tse</au><au>Liou, Gregory I</au><au>Brands, Michael W</au><au>Caldwell, Robert W</au><au>Caldwell, Ruth B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation</atitle><jtitle>Investigative ophthalmology & visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>51</volume><issue>3</issue><spage>1709</spage><epage>1718</epage><pages>1709-1718</pages><issn>0146-0404</issn><issn>1552-5783</issn><eissn>1552-5783</eissn><abstract>The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interactions between inflammatory agonists and angiotensin II in promoting retinopathy are poorly understood. The present study was an investigation of the role of interleukin (IL)-6 in angiotensin II-induced retinopathy.
Rats and IL-6-deficient and wild-type mice were treated with angiotensin II or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localization of VEGF or IL-6. Leukocyte adhesion was assayed by concanavalin A labeling. Vascular density was determined by morphometric analysis. NADPH oxidase activity was assayed by dihydroethidium imaging of superoxide.
Intravitreal injection of angiotensin II caused increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels. IL-6 protein was localized to CD11b-positive microglia and macrophage-like cells. Angiotensin II treatment stimulated increases in retinal levels of VEGF expression and NADPH oxidase activity, which were associated with increased surface area and remodeling of the retinal vessels. These effects were blocked by knocking out IL-6. Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient mice.
The results indicate that IL-6 expression is essential for angiotensin II-induced increases in retinal VEGF expression, leukostasis, and vascular remodeling. The data suggest a critical role for IL-6 in mediating angiotensin II-induced retinal vascular inflammation and remodeling.</abstract><cop>United States</cop><pub>ARVO</pub><pmid>19834028</pmid><doi>10.1167/iovs.09-3375</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0146-0404 |
ispartof | Investigative ophthalmology & visual science, 2010-03, Vol.51 (3), p.1709-1718 |
issn | 0146-0404 1552-5783 1552-5783 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2868419 |
source | PubMed Central |
subjects | Angiotensin II - pharmacology Animals Blotting, Western Cell Adhesion Enzyme-Linked Immunosorbent Assay Interleukin-6 - pharmacology Interleukin-6 - physiology Leukocytes - metabolism Leukostasis - chemically induced Leukostasis - prevention & control Mice Mice, Inbred C57BL Mice, Knockout Microscopy, Confocal NADPH Oxidases - metabolism Rats Rats, Sprague-Dawley Retinal Vasculitis - chemically induced Retinal Vasculitis - metabolism Retinal Vessels - drug effects Retinal Vessels - metabolism Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - metabolism Superoxides - metabolism Up-Regulation Vascular Endothelial Growth Factor A - metabolism Vasoconstrictor Agents - pharmacology |
title | Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A04%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20IL-6%20in%20Angiotensin%20II-Induced%20Retinal%20Vascular%20Inflammation&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Rojas,%20Modesto&rft.date=2010-03-01&rft.volume=51&rft.issue=3&rft.spage=1709&rft.epage=1718&rft.pages=1709-1718&rft.issn=0146-0404&rft.eissn=1552-5783&rft_id=info:doi/10.1167/iovs.09-3375&rft_dat=%3Cpubmed_cross%3E19834028%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19834028&rfr_iscdi=true |